Evolutionary biochemistry of disease

Evolutionary Biochemistry Of Disease enters the Adult Cognitive Disease corpus through the work of John Gruber (submission 51), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

John Gruber's submission is summarised in this corpus as:

Alzheimer's disease is fundamentally a protein denaturation disease driven by extracellular oxidative damage, analogous to coronary artery plaque formation. High-dose vitamin C (ascorbate) can reduce disulfide bonds in misfolded proteins, potentially clearing tau tangles and amyloid plaques through redox chemistry.

Where it sits

The submission scores against the framework's convergence nodes as: compensatory paradigm 2 · neuroimmune interface 2.

Its declared subject matter: vitamin-C, oxidative-damage, protein-denaturation, disulfide-bonds, redox-chemistry, evolutionary-biochemistry, antioxidants.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Cross-disease protein aggregation parallels · Protein denaturation as disease driver · Redox chemistry therapeutic approach.


Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.

Source: kb/wiki/concepts/Evolutionary biochemistry of disease.md